Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy

NCT01449786 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT01449786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01449786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy
Lead sponsor
Medical University of Vienna
Phase
Phase 2
Overall status
Completed
Start date
March 14, 2012
Completion date
December 20, 2016
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

birch pollen allergy, birch pollen related apple allergy